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PREVENTION RESEARCH
Perceived Versus Calculated HIV Risk: Implications for
Pre-exposure Prophylaxis Uptake in a Randomized Trial of
Men Who Have Sex With Men
Jill Blumenthal, MD,* Sonia Jain, PhD,* Evan Mulvihill, PharmD,* Shelly Sun, MS,*
Marvin Hanashiro, BA,* Eric Ellorin, MAS,* Sara Graber, BA,* Richard Haubrich, MD,† and
Sheldon Morris, MD, MPH*
Background: Inaccurate HIV risk perception by men who have
sex with men is a barrier to HIV prevention. Providing information
about objective HIV risk could improve pre-exposure prophylaxis
(PrEP) uptake.
Methods: PrEP Accessibility Research & Evaluation 2 (PrE-
PARE2) was a randomized controlled trial of men who have sex
with men to determine whether an objective risk score affects future
PrEP uptake. Participants completed a baseline survey to assess
demographics, risk behaviors, and HIV self-perceived risk (SPR).
The survey generated a calculated HIV risk (CalcR) score,
estimating HIV risk based on reported condomless anal intercourse
and sexually transmitted infections, and was provided to individuals
in the intervention arm. Participants were contacted 8 weeks later to
determine whether they initiated PrEP.
Results: Of 171 participants (median age 32 years; 37% Hispanic
or non-Hispanic Black; median 5 sexual partners in the past 6
months), 81% had heard of PrEP, and 57% believed they were good
PrEP candidates. SPR had poor agreement with CalcR (kappa =
0.176) with 38% underestimating their HIV risk. At week 8, only 14
of 135 participants had initiated PrEP with no difference between
arms (CalcR 11%, control 10%, P . 0.99). The most common
reason for not starting PrEP was low HIV risk perception. There was
a relative decrease in SPR over time (P = 0.06) but no difference
between arms (P = 0.29).
Conclusion: Providing an objective HIV risk score alone did not
increase PrEP uptake. HIV testing performed at testing sites may be
a crucial time to correct misperceptions about risk and initiate same-
day PrEP, given enthusiasm for PrEP on the testing day to facilitate
greater uptake.
Key Words: pre-exposure prophylaxis, HIV risk perception, men
who have sex with men
(J Acquir Immune Defic Syndr 2019;80:e23–e29)
INTRODUCTION
Three decades after the onset of the AIDS epidemic,
men who have sex with men (MSM) continue to bear
a disproportionate burden of HIV, accounting for 67% of
incident infections in the United States.1 The development
and licensure of oral pre-exposure prophylaxis (PrEP) with
tenofovir disoproxil fumarate and emtricitabine (TDF/FTC)
has raised hope in changing this trajectory.2 Promising trials
over the past several years suggest that taking PrEP sub-
stantially reduces the risk of HIV infection in high-risk
populations including MSM.3–6 Oral TDF/FTC has been
available through some demonstration projects and is cur-
rently covered by most public and private insurance pro-
viders, but may require financial assistance through the drug
manufacturer or other patient assistance programs.7,8
Despite high efficacy and insurance coverage, PrEP has
not been evenly implemented in high-risk communities,
which may result in a blunted population level impact.9,10
In our previous study, Pre-Exposure Prophylaxis Accessibil-
ity Research and Evaluation (PrEPARE), we examined
barriers to adopting this mode of HIV prevention among
MSM.11 Most subjects were concerned about long-term side
effects, daily pill-taking or cost, of which cost/insurance
coverage continues to be a significant barrier to PrEP uptake
and continuation.12 However, an additional 35% did not want
to take PrEP because they did not perceive themselves to be at
high risk of HIV infection. In contrast to their self-perceived
risk (SPR), over half of these responders reported unprotected
receptive anal sex exposure in the previous 12 months and 7%
reported having at least 25 different sex partners. These
findings highlight the strong disconnect between an individ-
ual’s perceived risk of infection and their actual risk that
would be estimated by behavioral and demographic
risk factors.
Risk perception is an individual’s subjective appraisal
of the likelihood of an undesirable outcome. Within the
context of HIV, it is the perception of the risk of acquiring
HIV and the seriousness afforded to seroconversion. It is
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inherently difficult to study because it encompasses both
conscious and unconscious thought processes. What con-
founds the situation further is that medical professionals
themselves cannot reach a consensus on what degree of
unsafe behavior should define low-, moderate-, and high-risk
populations.13,14 Data have shown that low SPR may
contribute to increased incidence of HIV in marginalized
populations and that there is a great divide between
perception and behavior.15–19 Reconciling perceived risk,
real-life behaviors, and validated risk indices is essential to
effectively implement preventive measures such as PrEP.20–23
Throughout the course of biomedicine, this reconcilia-
tion has often been achieved through the development of
objective risk calculators. Incidence of cardiovascular disease
and osteoporosis, for example, has been drastically reduced
through the use of Framingham and DXA scores, respec-
tively.24–26 The provision and use of an HIV risk score is
hoped to yield similar effects. In 2014, the Center for Disease
Control and Prevention (CDC) published the HIV Incidence
Risk Index for MSM (HIRI-MSM), the only nationally
established HIV risk calculator for MSM.22,27 In this trial,
we use this risk tool and a newly developed HIV risk tool,
based on specific HIV transmission events among MSM.
In this study, we investigated whether informing high-
risk MSM in San Diego County of their calculated HIV risk
would affect their uptake of PrEP and alter their perceived
risk. We hypothesized that although MSM would underesti-
mate their risk of HIV acquisition, informing them of their
calculated risk would create durable alterations in risk
perception and would increase PrEP uptake.
METHODS
Study Procedures
From April 2014 to June 2016, participants were
recruited from 3 San Diego HIV testing sites. All participants
tested negative by a rapid HIV antibody testing, followed by
HIV nucleic acid amplification testing. Inclusion criteria were
verified verbally by an independent interviewer who enrolled
the subject and included: HIV-negative by rapid test, MSM
older than 18 years, and at least 1 act of condomless anal
intercourse with an HIV-positive partner or partner of
unknown status in the past 6 months. Exclusion criteria
included current active usage of PrEP, inability to provide
written consent, lack of significant risk of acquiring HIV, and/
or signs or symptoms suggestive of acute HIV infection.
Eligible subjects were randomized 1:1 by a computer
program to the intervention or control arm. All subjects were
given an iPad survey that assessed demographics, SPR, and
risk behavior questions and generated an objective risk score.
The iPad survey contained 32 questions in total with 3 main
components: 3 questions assessing their level of SPR, 13
demographic questions, and 16 questions assessing risk
behaviors used to calculate 2 different objective risk scores,
the HIRI-MSM and the calculated HIV risk (CalcR) scores,
described in the following text in more detail. The survey was
only offered in English, and all participants referred for the
study were proficient in English.
After completing the survey, participants in the inter-
vention arm were provided their CalcR score result compared
with the average risk of HIV seroconversion in MSM, which
was then further categorized as low, moderate, high, or very
high risk, with a short explanation of each category. These
results were given to the intervention arm both on the iPad
and verbally by the interviewer. Both groups received
standard risk reduction counseling along with a brief descrip-
tion of PrEP and how to access it on their own if desired, but
no prescriptions or study drug were provided.
Participants were contacted by phone 8 weeks after the
enrollment/survey date (week 0) to determine whether they
initiated PrEP or not (defined as having taken a single dose or
more of PrEP in the 8-week period) and to reassess their HIV
risk. They were also asked to complete an online survey
(week 12) with questions about SPR and recent risk behaviors
to calculate a second CalcR score.
The study plan and subsequent changes were approved
by the University of California San Diego Human Research
Protections Program Institutional Review Board. The first 76
subjects were mailed a $5 gift card after completing the
follow-up phone call and online survey. To increase enroll-
ment, the subsequent 95 subjects were given a $5 gift card
after enrollment and a second $5 gift card on
study completion.
HIV Risk Measures
Objective
HIRI-MSM
As described above, the HIRI-MSM was developed
through statistical analysis of behavioral and HIV testing data
from 2 large prospective studies including 6654 MSM
participants.22 The HIRI-MSM uses the following 7 questions
to generate an HIV risk score: age, number of MSM partners,
number of HIV-positive partners, instances of unprotected
receptive anal intercourse, instances of unprotected insertive
anal intercourse, use of amphetamines, and use of poppers
over the past 6 months.22 Scores range from 0 to 47; scores of
10 or higher confer substantial HIV risk and should prompt
providers to discuss HIV prevention strategies including
PrEP.27
CalcR Score
The CalcR Score was developed as an alternative tool
to evaluate HIV risk based on patient-specific HIV trans-
mission events. The score is generated from a mathematical
equation that focuses on sexual transmission methods and
biological factors that may increase HIV acquisition: con-
domless receptive and insertive anal intercourse acts and
sexually transmitted infections (STIs) including gonorrhea,
chlamydia, syphilis, and herpes. It previously included shared
needle events via injection drug use (IDU) but was removed
because of extremely few self-reported IDU events in this
study and a previous study using the CalcR Score.28 It
incorporates event frequencies over the past month and
established event probabilities of HIV transmission because
of condomless anal intercourse acts29 or STI occurrence.30 As
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sex frequency is a potential driver of HIV and STI risk among
MSM, estimates of sex frequency combined with estimates of
HIV risk per sexual act may be useful to model risk by sexual
behaviors.31 In addition, the short time frame used reduces
recall bias that may occur in highly sexually active co-
horts.32,33 The calculated risk score is extrapolated to the
percent likelihood of HIV seroconversion in 1 year if their
sexual activities persisted at the same rate and is categorized
into low (,0.12%), moderate (0.12%–0.59%), high (0.6%–
5.9%), and very high (.5.9%) risk groups. Classification is
based on the average percent likelihood of HIV seroconver-
sion among MSM in the United States.34 Further details on
the CalcR score are available in Supplementary Materials.
The CalcR score has not been validated in prospective clinical
studies primarily because of the specific data collected, which
include condomless anal sex act frequency per partner over
a short period of time. Traditional sexual risk surveys among
MSM elicit information regarding sexual behaviors including
number of sex partners over long recall periods (eg, 3 or 6
months), despite the known effect of number of sex acts (or
possible HIV exposures) on HIV acquisition risk.35
Subjective
SPR Score
The SPR score is based on 3 questions about self-
perceived HIV risk adopted from a validated HIV SPR
survey21 using Likert scales: (1) How likely is it that you
will become HIV-positive in the next year? (0 = extremely
unlikely; 1 = very unlikely; 2 = somewhat likely; 3 = very
likely; or 4 = extremely likely); (2) How likely is it that you
will become HIV-positive in your lifetime? (0 = extremely
unlikely; 1 = very unlikely; 2 = somewhat likely; 3 = very
likely; or 4 = extremely likely); and (3) My gut feeling is that
I will NOT get infected with HIV (0 = strongly disagree; 1 =
disagree; 2 = somewhat disagree; 4 = agree; or 5 = strongly
agree). The SPR score was calculated as the sum of 3
questions and ranged from 0 to 13 and was divided into 4 risk
categories: low (0–3), moderate (4–6), high (7–9), and very
high (10–13). The SPR score was obtained at weeks 0 and 12.
Self-perceived Likelihood of HIV Acquisition (LHA Score)
The LHA score is the percent likelihood from 0% to
100% that participants believed they would become HIV-
infected in the next year. At weeks 0 and 12, it was obtained
through a survey, and at week 8, it was reported to the study
coordinator by phone.
Statistical Analysis
Baseline characteristics were summarized and com-
pared between study arms using the Wilcoxon rank-sum test
for continuous variables and the Fisher exact test for
categorical variables. Cross-tabulation was used to compare
SPR versus CalcR and HIRI-MSM risk categories. Cohen’s
kappa coefficient was calculated to assess the agreement
between the subjective and objective risk measures. Self-
perceived underestimation of HIV risk was defined if SPR
score category was below the CalcR risk category.
The primary outcome was the initiation of PrEP at week
8. The Fisher exact test was used to compare the proportions
between the study arms. Secondary outcomes included the
FIGURE 1. Participant study flow. CAI,
condomless anal intercourse.
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proportion of those considering PrEP and change in objective
and subjective risk measures. The Wilcoxon signed-rank test
was used to assess the overall change, and the Wilcoxon rank-
sum test was used to compare the change between study arms.
A P value of ,0.05 was considered statistically significant.
No adjustments were made for multiple comparisons. Statis-
tical analyses were performed in R (http://cran.r-project.org),
version 3.3.3.
RESULTS
Participant Flow and Baseline Characteristics
A total of 204 MSM were approached for the study if
they expressed interest in the study and potentially met study
criteria based on information they provided to HIV testing
counselors during testing. Thirty-three of these individuals
were ineligible to participate because of lack of sufficient risk
(ie, did not have any condomless anal sex with a HIV-positive
or unknown status partner) or already on PrEP. One hundred
seventy-one individuals were enrolled and randomized to
control or intervention arms. Retention was 79% (n = 135) for
the primary endpoint at week 8 and 67% (n = 119) at week 12
(Fig. 1). Of 171 participants enrolled, the median age was 32
years [interquartile range (IQR) 25–42], 29% identified as
Latino, 60% as White, and 8% as Black. Ninety-two percent
had some college education or more, 55% earned less than
$3000 per month, and 16% were uninsured. The median
number of sexual partners in the past 6 months was 5 (IQR 3–
10). Thirty percent of participants reported drug use in the
past 6 months with 5% using methamphetamines and 14%
using amyl nitrates (ie, poppers). Although only n = 7 (4%)
had used PrEP before, 81% had heard of PrEP and 57%
believed they would be a good candidate to take PrEP.
Objective and subjective measures of risk were balanced
between arms. Further details are shown in Table 1.
Comparison of Subjective and Objective
HIV Risk
Based on the SPR score, n = 90 (53%) considered
themselves low risk, n = 65 (38%) moderate risk, and n = 16
(9%) high or very high risk. The median CalcR score was
0.26% (IQR 0.1%–0.44%) with n = 60 (35%) categorized as
low risk, n = 79 (46%) as moderate risk, and n = 32 (19%) as
high or very high risk. Thus, n = 65 (38%) underestimated
their HIV risk, n = 83 (49%) had concordant predictions, and
n = 23 (13%) overestimated their risk (kappa = 0.176) (Table
2). The 32 MSM in the CalcR high-risk category were
particularly poor at estimating their risk with over 90%
underestimating their risk. Using the HIRI-MSM score, the
mean HIRI-MSM score was 18 (SD 8) with n = 24 (14%)
categorized as low risk and n = 147 (86%) as high risk. When
comparing SPR score with HIRI-MSM, n = 75 (44%)
underestimated their risk, n = 87 (51%) had concordant
predictions, and only n = 9 (5%) overestimated their risk
(kappa = 0.053) (Table 3).
Comparison of Objective HIV Risk Scores
Table 4 shows the comparison between the CalcR risk
and HIRI-MSM risk. Only 8 of the 111 individuals in the
moderate or high CalcR risk group were classified as low risk
by the HIRI-MSM. However, nearly three-quarters (44/60) of
the individuals considered low risk by CalcR were classified
as high risk by HIRI-MSM, resulting in overall moderate
concordance (kappa = 0.226) (Table 4).
PrEP Uptake
At week 8, n = 135 participants were reached for
follow-up, notably n = 76 (88%) in the intervention arm and n
= 59 (69%) in the control arm (P = 0.003). Attrition rate for
the primary endpoint was 21%, with these participants
unreachable by phone despite repeated call attempts. Of the
135 who reached for follow-up, only n = 14 (10%) started
PrEP including n = 8/76 (11%) who received their risk score
and n = 6/59 (10%) who did not. Nearly 70% (n = 93)
TABLE 1. Demographics and Baseline Risk Behaviors
Control n = 85,
N (%)
Intervention
n = 86, N
(%)
Total n = 171,
N (%)
Age* 36 (27–44) 30 (24–40) 32 (25–42)
Race
White 51 (60%) 51 (59%) 102 (60%)
Black 7 (8%) 6 (7%) 13 (8%)
Other 27 (32%) 29 (34%) 56 (33%)
Ethnicity
Latino 20 (26%) 26 (31%) 46 (29%)
Education†
Some college or
higher
81 (95%) 76 (88%) 157 (92%)
Monthly income
,$3000 39 (48%) 50 (63%) 89 (55%)
Insurance
Public 12 (14%) 13 (15%) 25 (15%)
Private 53 (62%) 53 (62%) 106 (62%)
None 15 (18%) 13 (15%) 28 (16%)
No. of partners past 6
months*
5 (3–10) 5 (3–10) 5 (3–10)
Substance use 23 (27%) 29 (34%) 52 (30%)
Methamphetamine use 4 (5%) 4 (5%) 8 (5%)
Popper use 10 (12%) 14 (16%) 24 (14%)
PrEP awareness 71 (84%) 68 (79%) 139 (81%)
Previous PrEP use 3 (4%) 4 (5%) 9 (5%)
Perceived PrEP
candidacy
47 (55%) 50 (58%) 97 (57%)
SPR score* 3 (2–5) 4 (3–5) 3 (2–5)
SPR HIV transmission
score*
14 (4–32) 16 (10–28) 15 (6–29)
CalcR score* 0.23 (0–0.42) 0.26 (0.1–
0.51)
0.26 (0.1–0.44)
HIRI-MSM* 18 (11–23) 18 (14–22) 18 (13–22)
P values ,0.05.
*Median (IQR).
†P values ,0.05 except for education.
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believed about starting PrEP with n = 54 (71%) in the
intervention and n = 39 (66%) in the control. There were no
differences by arm in either PrEP uptake or consideration. We
did find that higher risk participants by CalcR were more
likely to be on PrEP at follow-up compared with those with
lower risk, regardless of risk score receipt (15% in high and
moderate risk groups versus 2% in the low-risk group (P =
0.042). Of the 121 participants who did not start PrEP, the
most common reasons were low SPR (36%) and concerns
about side effects (19%) with no difference by arm. Of note, n
= 18 (15%) reported waiting to get into a study or see
a provider to get PrEP. We included these participants as
having reached the primary endpoint and observed a slight
separation in PrEP uptake in the intervention and control
groups but still did not observe a statistically significant
difference (28% versus 19%, P = 0.31). A complete summary
of participants’ reasons for not going on PrEP is shown in
Table 5.
Change in Subjective HIV Risk
SPR was compared at baseline and week 12. There was
a trend toward decreased SPR overall (median = 0, IQR: 22
to 1, P = 0.06) but no difference between study arms (P =
0.29). The LHA score was compared at baseline, week 8, and
week 12. Overall, there was a significant decrease in LHA
score from baseline to week 8 (median =23.6%, IQR:215%
to 5.5%, P = 0.006) but no difference by study arm (P =
0.604). From baseline to week 12, there was a trend toward
decreased LHA overall (median = 21.8%, IQR: 211.5% to
5%, P = 0.06) but no difference by study arm (P = 0.39).
There was no change in perceived PrEP candidacy between
baseline and week 12 (57% versus 58%, P . 0.99).
DISCUSSION
Despite enrolling a high-risk population of MSM who
often underestimated their risk for HIV acquisition, providing
an objective HIV risk score to individuals did not increase
their likelihood of starting or even considering PrEP. Our
study suggests that by itself, a risk score elucidating actual
HIV risk may not be enough to increase PrEP uptake.
However, individuals who received their HIV risk score were
more likely to follow-up, which may indicate some acknowl-
edgment of true risk and interest in PrEP. An assessment of
HIV risk may be a starting point for further discussion around
prevention methods.
MSM who test at dedicated HIV-testing sites may be
acceptable to discussion and even initiation of PrEP.
Although there are individuals who regularly test and who
may be part of the “worried well,” 65% of our study
population was found to be at substantial objective risk of
HIV acquisition based on CalcR score and 85% with the
HIRI-MSM score at baseline. The reason for this discrepancy
between CalcR and HIRI-MSM risk scores is likely due to
a higher dependency of objective HIV risk related to
condomless sex acts during a discrete period of time in
CalcR compared with a composite of behavioral factors in
HIRI-MSM over a longer time course. This difference could
be interpreted as CalcR missing individuals with certain high-
risk behaviors (eg, methamphetamines). Alternatively, CalcR
scores may be more accurate because it recognizes that non-
IDU does not in itself confer HIV risk—it is the associated
sexual acts that are pertinent. In addition, the shorter time
period used in CalcR score decreases the potential for recall
bias. Of the 14 individuals who initiated PrEP, it is worth
noting that 93% of these PrEP users had moderate (n = 9) or
high (n = 4) objective HIV risk. This finding not only
indicates that PrEP was appropriately used by those at
substantial risk of HIV in our study but also suggests that
the CalcR risk score may be a useful tool to predict which
individuals will start PrEP. To determine whether patient-
specific HIV transmission events can accurately predict HIV
acquisition, further validation of CalcR is needed against an
HIV acquisition data set with event-level data for STIs and
the number of sex acts that preceded HIV incident cases.
TABLE 2. Objective Compared With Subjective HIV Risk
(CalcR Versus SPR)
CalcR
Low Moderate High/Very High Total
SPR
Low 42 (25%) 36 (21%) 12 (7%) 90
Moderate 10 (6%) 38 (22%) 17 (10%) 65
High/very high 8 (5%) 5 (3%) 3 (2%) 16
Total 60 79 32 171
Forty-nine percent concordant (bold); 38% underestimated risk (italics); and 14%
overestimated risk (bold italics) (kappa = 0.176).
TABLE 3. Objective Compared With Subjective HIV Risk (HIRI-
MSM Score Versus SPR)
HIRI-MSM
Low High Total
SPR
Low 15 (9%) 75 (44%) 90
.Low 9 (5%) 72 (42%) 81
Total 25 146 171
Fifty-one percent concordant (bold); 44% underestimated risk (italics); and 5%
overestimated risk (bold italics) (kappa = 0.053).
TABLE 4. Comparison of Objective HIV Risk (CalcR Versus
HIRI-MSM)
HIRI-MSM
Low High Total
CalcR
Low 16 (9%) 44 (26%) 60
Moderate/high 8 (5%) 103 (60%) 111
Total 24 147 171
Sixty-nine percent concordant (bold); 26% high-risk HIRI-MSM/low-risk CalcR
(italics); and 5% high-risk CalcR/low-risk HIRI/MSM (bold italics) (kappa = 0.226).
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In addition, despite no statistically significant change in
self-perceived HIV risk throughout the study, there was
a trend toward lower SPR at follow-up. Studies have found
that perceived elevated risk is a common reason for HIV
testing that underscores the importance of discussing and
offering PrEP around HIV testing.36,37 After receiving risk
reduction counseling, individuals may also believe they can
make behavioral changes to gain better control over their HIV
risk. Thus, affording individuals’ time and space to consider
PrEP and other HIV prevention strategies could ultimately
dissuade them from starting PrEP.
As in previous studies, many individuals underesti-
mated their risk of HIV acquisition compared with actual
risk.38–40 Low perceived HIV risk has been shown to be
related to erroneous beliefs about HIV transmission and
epidemiology.41,42 Thus, PrEP screening in MSM should
include education about behaviors that increase HIV acqui-
sition risk. Beyond HIV knowledge, HIV risk perception in
MSM is likely influenced by nonepidemiologic factors
including relationship type, partner trust, and perceived threat
of HIV infection,43 which objective risk scores do not take
into account. As a result, there may be instances when
objective risk is overestimated and subjective risk is more
accurate. Further research is needed to understand the
constructs that shape HIV risk perception, which may lead
to better alignment of subjective and objective HIV risk and
more appropriate HIV prevention interventions for MSM.
The study had several limitations. Most significantly,
the study was underpowered because of initial slow study
uptake and attrition at week 8. In addition, follow-up at 8
weeks may not have been sufficient time to reach the primary
endpoint. As a result, it is difficult to draw final conclusions
about PrEP uptake and consideration. Data capture was
different at all 3 time points because of study constraints
with the use of an iPad survey at the study site at baseline,
verbal report through phone call to the study coordinator at
week 8, and an online survey to be completed at the
participant’s choosing at week 12. Similar to HIRI-MSM,
our intervention also does not adjust for viral load of
partnership and therefore can overestimate actual risk for
individuals who have partners with suppressed viral loads.
Assessing viral status of HIV-infected partners is difficult, as
it relies on accurate knowledge of partners’ HIV status, ART
use, and adherence. Providing ranges of risk probability with
and without partner viral suppression could be a strategy to
improve the validity of CalcR scores. Finally, as previously
discussed, the CalcR score and categories have not yet been
validated in prospective studies of HIV incidence because of
data element incompatibility with traditional sexual
behavior questions.
In this cohort of at-risk MSM, providing an objective
HIV risk score alone did not increase future PrEP uptake or
change self-perceived HIV risk despite most recognizing
PrEP candidacy. Discordance between perceived and actual
risk may be a barrier to effective PrEP implementation, and
efforts to develop population-specific HIV risk tools that
combine an assessment of both local epidemiological and
behavioral risk. Nevertheless, because HIV risk perception
may be slightly higher around HIV testing, HIV testing may
be a crucial time to help correct misperceptions about HIV
risk and acquisition and initiate same-day PrEP to facilitate
greater uptake.
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